James Wentworth

James Wentworth, PhD, MBA, is an accomplished business leader currently serving as Chief Business Officer at Transgene since January 2024. Prior to this role, James held various positions at Adaptimmune from October 2017 to January 2024, advancing from Senior Business Development Analyst to Director of Business Development & Strategy. James possesses extensive experience in commercial strategy and operations within the biotechnology sector, having worked at inVentiv Health and Shire Pharmaceuticals. James's educational background includes a Master of Business Administration from IMD, where there was a strong focus on Finance, Entrepreneurship, and Accounting, as well as a PhD in Pharmacology and a Bachelor's degree in the same field from the University of Bristol.